WUXI BIOLOGICS (CAYMAN) INC UNS (WXXWY) Financials

WXXWY Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 7.2 billion 1.8 billion
2023-03-31 1.6 billion 412.7 million
2022-12-31 7.2 billion 1.9 billion
2022-09-30 ? ?

WXXWY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 108.0 million 108.0 million
2023-03-31 -112.7 million 19.4 million
2022-12-31 130.6 million 101.2 million
2022-09-30 ? ?

WXXWY Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-06-30 312.9 million
2023-03-31 145.5 million
2022-12-31 273.6 million
2022-09-30 ?

WXXWY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 1.2 billion - 321.0 million
2023-03-31 405.4 million - -
2022-12-31 1.3 billion - 237.8 million
2022-09-30 - - -

WXXWY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 600.4 million
2023-03-31 322.3 million
2022-12-31 633.6 million
2022-09-30 ?

WXXWY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 1.8 million 47.1 million 93.8 million 14.5 million
2023-03-31 237.7 million 18.3 million 36.5 million 4.5 million
2022-12-31 462.1 million 60.7 million 108.8 million 13.9 million
2022-09-30 - - - -

WXXWY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 1.2 billion 680.6 million
2023-03-31 375.0 million 199.0 million
2022-12-31 1.2 billion 689.6 million
2022-09-30 - -

WXXWY

Price: $3.36

52 week price:
3.19
13.84

Earnings Per Share: 0.21 USD

P/E Ratio: 15.63

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 20500

Market Capitalization: 7.5 billion

Links: